Search

everythinglearnresearchcommunity

for

Search:↓

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

Most diabetic patients have skin problems, which are more common with longer diabetes duration and poor blood sugar control.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Premature hair greying may indicate a higher risk of metabolic problems.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Early hair greying may increase the risk of heart disease.

Women with different PCOS types have similar fertility treatment results.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

People with male pattern baldness are more likely to have metabolic syndrome.

Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.

Alopecia areata patients may have higher blood pressure and blood sugar, indicating a future risk of metabolic issues.

Early-onset male hair loss may be linked to higher cardiovascular risk.

Insulin resistance is linked to higher hormone levels in women with PCOS.

Diabetes can cause hair thinning, increased hair loss, and changes in hair growth phases.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Higher testosterone levels in Nigerian women with PCOS are linked to glucose disorders like diabetes.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Osteopontin levels are higher in people with androgenetic alopecia and are linked to metabolic disorders.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.